Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands

被引:19
|
作者
Shpakov, Alexander O. [1 ]
机构
[1] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia
关键词
G protein-coupled receptor; allosteric site; allosteric modulator; pepducin; heterotrimeric G protein; autoantibody; thyroid-stimulating hormone receptor; luteinizing hormone receptor; proteinase-activated receptor; chemokine receptor; LUTEINIZING-HORMONE RECEPTOR; CELL-PENETRATING PEPDUCINS; METABOTROPIC GLUTAMATE RECEPTORS; THYROTROPIN-RECEPTOR; TSH-RECEPTOR; STIMULATING-HORMONE; BIASED-AGONISM; ACTIVATED RECEPTOR-1; BIOLOGICAL-ACTIVITY; SIGNALING SYSTEM;
D O I
10.3390/ijms24076187
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Allosteric regulation is critical for the functioning of G protein-coupled receptors (GPCRs) and their signaling pathways. Endogenous allosteric regulators of GPCRs are simple ions, various biomolecules, and protein components of GPCR signaling (G proteins and b-arrestins). The stability and functional activity of GPCR complexes is also due to multicenter allosteric interactions between protomers. The complexity of allosteric effects caused by numerous regulators differing in structure, availability, and mechanisms of action predetermines the multiplicity and different topology of allosteric sites in GPCRs. These sites can be localized in extracellular loops; inside the transmembrane tunnel and in its upper and lower vestibules; in cytoplasmic loops; and on the outer, membrane-contacting surface of the transmembrane domain. They are involved in the regulation of basal and orthosteric agonist-stimulated receptor activity, biased agonism, GPCR-complex formation, and endocytosis. They are targets for a large number of synthetic allosteric regulators and modulators, including those constructed using molecular docking. The review is devoted to the principles and mechanisms of GPCRs allosteric regulation, the multiplicity of allosteric sites and their topology, and the endogenous and synthetic allosteric regulators, including autoantibodies and pepducins. The allosteric regulation of chemokine receptors, proteinase-activated receptors, thyroid-stimulating and luteinizing hormone receptors, and beta-adrenergic receptors are described in more detail.
引用
收藏
页数:54
相关论文
共 50 条
  • [31] MOLECULAR MECHANISMS OF ACTIVATION AND DESENSITIZATION OF G-PROTEIN-COUPLED RECEPTORS
    LEFKOWITZ, RJ
    BIOPHYSICAL JOURNAL, 1994, 66 (02) : A139 - A139
  • [32] G-protein coupled receptors as allosteric machines
    Kenakin, T
    RECEPTORS & CHANNELS, 2004, 10 (02): : 51 - 60
  • [33] Allosteric modulation of G-protein coupled receptors
    Jensen, AA
    Spalding, TA
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (04) : 407 - 420
  • [34] Allosteric modulation of G protein-coupled receptors
    May, LT
    Avlani, VA
    Sexton, PM
    Christopoulos, A
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (17) : 2003 - 2013
  • [35] Allosteric modulation of G protein-coupled receptors
    May, Lauren T.
    Leach, Katie
    Sexton, Patrick M.
    Christopoulos, Arthur
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 : 1 - 51
  • [36] Allosteric modulation of G protein-coupled receptors
    Soudijn, W
    van Wijngaarden, I
    Ijzerman, AP
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (05) : 749 - 755
  • [37] Allosteric Modulators of G Protein-Coupled Receptors
    Shpakov, Alexander
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [38] Allosteric Modulators of the Class A G Protein Coupled Receptors
    Tschammer, Nuska
    PROTEIN TARGETING COMPOUNDS: PREDICTION, SELECTION AND ACTIVITY OF SPECIFIC INHIBITORS, 2016, 917 : 185 - 207
  • [39] Allosteric modulation of G protein-coupled receptors
    Ijzerman, A
    Kourounakis, A
    van der Klein, P
    FARMACO, 2001, 56 (1-2): : 67 - 70
  • [40] Allosteric Modulators of G Protein-Coupled Receptors
    Wells, Gregory J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (15) : 1735 - 1737